Frederick Cohen
Impact in
- Organic Chemistry top 5%
- Advanced Synthetic Organic Chemistry
- Asymmetric Synthesis and Catalysis
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Advanced Synthetic Organic Chemistry 5
- Asymmetric Synthesis and Catalysis 3
- Synthesis and Biological Evaluation 2
-
- Cell death mechanisms and regulation 8
- Co-authors
- Larry E. Overman (9 shared papers)Sylvie K. Ly Sakata (1 shared paper)Shawn K. Collins (2 shared papers)Chudi O. Ndubaku (2 shared papers)Domagoj Vucic (2 shared papers)Vickie Tsui (3 shared papers)Satyajit Ray (1 shared paper)Carole A. Bewley (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (7 papers)Organic Letters (3 papers)ChemMedChem (3 papers)Journal of the American Chemical Society (3 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesChina
In The Last Decade
Frederick Cohen
29 papers receiving 1.5k citations
Frederick Cohen's Hit Papers
Peers
Comparison fields: 5 of 69
- Organic Chemistry 459
- Molecular Medicine 93
- Molecular Biology 740
- Computational Theory and Mathematics 165
- Cancer Research 93
Countries citing papers authored by Frederick Cohen
This map shows the geographic impact of Frederick Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Cohen more than expected).
Fields of papers citing papers by Frederick Cohen
This network shows the impact of papers produced by Frederick Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Cohen. The network helps show where Frederick Cohen may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick Cohen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 281 | |
| 2 | 2012 | 211 | |
| 3 | Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton’s Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies Hit paper breakdown → | 2024 | 85 |
| 4 | 2014 | 77 | |
| 5 | 2001 | 76 | |
| 6 | 2017 | 75 | |
| 7 | 2019 | 65 | |
| 8 | 2004 | 57 | |
| 9 | 2019 | 55 | |
| 10 | 1999 | 54 | |
| 11 | 2006 | 51 | |
| 12 | 1998 | 44 | |
| 13 | 2004 | 44 | |
| 14 | 2012 | 43 | |
| 15 | 2006 | 39 | |
| 16 | 2009 | 35 | |
| 17 | 2012 | 32 | |
| 18 | 2013 | 32 | |
| 19 | 2009 | 30 | |
| 20 | 2019 | 28 |
About Frederick Cohen
Frederick Cohen is a scholar working on Organic Chemistry, Molecular Biology, Molecular Medicine, Cancer Research and Virology, having authored 29 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (8 papers), Advanced Synthetic Organic Chemistry (5 papers), Asymmetric Synthesis and Catalysis (3 papers), Computational Drug Discovery Methods (3 papers), Antibiotic Resistance in Bacteria (3 papers), Protease and Inhibitor Mechanisms (2 papers), HIV Research and Treatment (2 papers) and Synthesis and Biological Evaluation (2 papers). The work is most often cited by research in Organic Chemistry (459 citations), Molecular Medicine (93 citations), Molecular Biology (740 citations), Computational Theory and Mathematics (165 citations) and Cancer Research (93 citations). Frederick Cohen has collaborated with scholars based in United States and China. Frequent co-authors include Larry E. Overman, Sylvie K. Ly Sakata, Shawn K. Collins, Chudi O. Ndubaku, Domagoj Vucic, Vickie Tsui, Satyajit Ray, Carole A. Bewley, Eugene E. Varfolomeev and Jeremy M. Murray. Their work appears in journals such as Journal of Medicinal Chemistry, Organic Letters, ChemMedChem, Journal of the American Chemical Society and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.